Detalhe da pesquisa
1.
Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
Cardiology
; 146(6): 705-712, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343998
2.
SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
Scand Cardiovasc J
; 54(6): 339-345, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400206
3.
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.
Scand Cardiovasc J
; 48(3): 148-55, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548278
4.
Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
Am J Cardiol
; 103(3): 345-9, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19166687
5.
Absence of metal allergy in patients with very late drug-eluting stent thrombosis: a pilot study.
Int J Cardiol
; 145(3): 629-30, 2010 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20965590
6.
[SORT OUT II--a randomized study of drug-eluting coronary stents--secondary publication]. / SORT OUT II--en randomiseret undersøgelse af medicinafgivende koronare stents--Sekundaerpublikation.
Ugeskr Laeger
; 171(4): 226-8, 2009 Jan 19.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-19180775